Skip to content

Author

Arionget Jemima

We have 4 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Nano-Enabled Phytotherapy in Diabetes Management: Targeted Delivery Systems for Plant-Derived Antidiabetic Compounds

Diabetes mellitus (DM) remains a global metabolic disorder characterized by chronic hyperglycemia and progressive microvascular and macrovascular complications. Although plant-derived bioactive compounds have demonstrated promising antidiabetic properties including insulin sensitization, β-cell protection, α-glucosidas...

Arionget Jemima · 0 citations
Review Sep 2026

Molecular Signatures of Oxidative Stress Across Organ Systems: Implications for Rheumatoid Factor, Diabetes, and Hepatic Injury

Oxidative stress is a central molecular mechanism underlying diverse pathological conditions. It results from an imbalance between pro-oxidant species and antioxidant defenses, leading to widespread molecular damage via lipid peroxidation, protein oxidation, DNA damage, and perturbation of redox homeostasis. This revie...

Arionget Jemima · 0 citations
Review Sep 2026

Artificial Intelligence for Predictive Analytics in Nigeria’s Energy Sector: A Review, Use-Case Map, and Implementation Roadmap

Nigeria’s energy sector faces persistent challenges: demand–supply imbalance, grid instability, high technical/commercial losses, fuel supply constraints, and operational downtime across electricity and hydrocarbons. Predictive analytics (forecasting, anomaly detection, predictive maintenance, and risk prediction) powe...

Arionget Jemima · 0 citations
Review Sep 2026

mRNA Vaccine Platforms Targeting HIV 1 Envelope Glycoproteins: Current Progress and Future Directions

Accumulating data indicated that mRNA platforms permitted precise encoding of stabilized envelope trimers, germline targeting constructs, and mosaic immunogens, resulting in improved antigen expression and enhanced induction of neutralizing antibody precursors in animal models and early human trials.

Arionget Jemima · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.